The WEB™ Aneurysm Embolization System expands with a lower profile delivery system and new size configurations. ALISO VIEJO, Calif., Jan. 12, 2021 /PRNewswire/ -- MicroVention, Inc., a U.S.-based ...

SAN DIEGO, California — The Woven EndoBridge Intrasaccular Therapy device (WEB) proved safe and effective for treating wide-neck bifurcation aneurysms in the prospective, single-arm WEB-IT study. The ...

SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year ...

ALISO VIEJO, Calif., Jan. 7, 2019 /PRNewswire/ -- MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the WEB ...

A prospective multicenter study reports that Woven EndoBridge intrasaccular therapy safely and effectively treats unruptured wide-necked bifurcation aneurysms, one of the most challenging brain ...

A prospective multicenter study of 59 Chinese patients with unruptured WNBAs treated with the WEB™ device showed a 98.3% technical success rate. At one year, 82% achieved adequate occlusion and 56% ...

Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...

This procedure works well for intracranial aneurysms and there are no serious concerns about its safety. An intracranial aneurysm is a bulge in a blood vessel in the brain caused by a weakness in the ...

Prospective multicenter study finds Woven EndoBridge therapy safe and effective for unruptured wide-necked bifurcation aneurysms in Chinese patients BEIJING, BEIJING ...